The European nerve repair and regeneration market comprises various types of products that can be segmented into nerve repair by biomaterials and nerve repair by neurostimulation, of which nerve repair by neurostimulation holds the highest market share of 66.4%, followed by nerve repair by biomaterials with a market share of 33.6%.
The European nerve repair and regeneration market displays growth that is projected to grow at a CAGR of 11.9% by 2019. This growth is driven by a number of drivers such as technological advancements and increasing number of neuro injuries that have provided a whole lot of growth opportunities for the market.
In the European region, the maximum market share is held by Germany and France; there has been a growth trend in this region over the past few years, due to the increasing diseases related to nerves such as Parkinson’s and epilepsy, as these are the major application areas for the devices; however, nerve repair by neurostimulation is widely used. The report focuses on an in-depth growth analysis in terms of market values in the respective geography and the market share of various companies that excel in these areas.
Technological advancements have been a backbone in increasing the market, which has been deeply analysed and added in the report. Due to the increasing demand and potential for these devices, the government has also extended its support; however, some stringent rules and regulations such as the implementation of taxes may still hamper the growth in the market.
A competitive analysis of the reports has been provided on the basis of companies that have been worked through diagrams and pie charts. It involves leaders such as Integra life sciences Corporation, Axogen, Stryker, Baxter International Inc., etc.